FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114218901> ?p ?o ?g. }

• W2114218901 endingPage "238" @default.
• W2114218901 startingPage "234" @default.
• W2114218901 abstract "Background Decreased beta-cell mass, mainly due to apoptosis, is crucial for the development and progression of type 2 diabetes. Chronic exposure to high glucose levels is a probable underlying mechanism, whereas the role of oral anti-diabetic agents (sulphonylureas in particular) is still unsettled. Methods To directly investigate more on such issues, we prepared isolated human islets, which were then cultured for 5 days in continuous normal glucose concentration (NG, 5.5 mmol/L) or normal and high (HG, 16.7 mmol/L) glucose levels (alternating every 24 h), with or without the addition of therapeutical concentration (10 µmolL) of gliclazide or glibenclamide. Results Intermittent high glucose caused a significant decrease of glucose-stimulated insulin secretion, which was not further affected by either sulphonylurea. Apoptosis, as assessed by electron microscopy, was also significantly increased by alternating high glucose exposure, which was accompanied by altered mitochondria morphology and density volume, and increased concentrations of nitrotyrosine, a marker of oxidative stress. Gliclazide, but not glibenclamide, was able to significantly reduce high glucose induced apoptosis, mitochondrial alterations, and nitrotyrosine concentration increase. Conclusion Therefore, gliclazide protected human beta-cells from apoptosis induced by intermittent high glucose, and this effect was likely to be due, at least in part, to the anti-oxidant properties of the molecule. Copyright © 2006 John Wiley & Sons, Ltd." @default.
• W2114218901 created "2016-06-24" @default.
• W2114218901 creator A5000550995 @default.
• W2114218901 creator A5032933055 @default.
• W2114218901 creator A5034383160 @default.
• W2114218901 creator A5048913575 @default.
• W2114218901 creator A5049269121 @default.
• W2114218901 creator A5049957859 @default.
• W2114218901 creator A5072567218 @default.
• W2114218901 creator A5073053873 @default.
• W2114218901 creator A5074935860 @default.
• W2114218901 creator A5080129058 @default.
• W2114218901 creator A5087771312 @default.
• W2114218901 creator A5090610183 @default.
• W2114218901 date "2007-01-01" @default.
• W2114218901 modified "2023-09-26" @default.
• W2114218901 title "Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose" @default.
• W2114218901 cites W1492642476 @default.
• W2114218901 cites W1982293047 @default.
• W2114218901 cites W1985950449 @default.
• W2114218901 cites W1997008557 @default.
• W2114218901 cites W2005754586 @default.
• W2114218901 cites W2008677894 @default.
• W2114218901 cites W2016746758 @default.
• W2114218901 cites W2020503356 @default.
• W2114218901 cites W2028212562 @default.
• W2114218901 cites W2051057821 @default.
• W2114218901 cites W2053463749 @default.
• W2114218901 cites W2055791664 @default.
• W2114218901 cites W2069150029 @default.
• W2114218901 cites W2075227327 @default.
• W2114218901 cites W2078105435 @default.
• W2114218901 cites W2078729207 @default.
• W2114218901 cites W2082936821 @default.
• W2114218901 cites W2085361695 @default.
• W2114218901 cites W2091360147 @default.
• W2114218901 cites W2097784879 @default.
• W2114218901 cites W2098036900 @default.
• W2114218901 cites W2105497606 @default.
• W2114218901 cites W2105654121 @default.
• W2114218901 cites W2114299222 @default.
• W2114218901 cites W2124146192 @default.
• W2114218901 cites W2126700142 @default.
• W2114218901 cites W2152656461 @default.
• W2114218901 cites W2159570963 @default.
• W2114218901 cites W2160176350 @default.
• W2114218901 cites W2166341528 @default.
• W2114218901 cites W2171277393 @default.
• W2114218901 cites W2337454357 @default.
• W2114218901 cites W2752336761 @default.
• W2114218901 cites W2769264260 @default.
• W2114218901 cites W4240940664 @default.
• W2114218901 cites W4249975860 @default.
• W2114218901 doi "https://doi.org/10.1002/dmrr.680" @default.
• W2114218901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16952202" @default.
• W2114218901 hasPublicationYear "2007" @default.
• W2114218901 type Work @default.
• W2114218901 sameAs 2114218901 @default.
• W2114218901 citedByCount "108" @default.
• W2114218901 countsByYear W21142189012012 @default.
• W2114218901 countsByYear W21142189012013 @default.
• W2114218901 countsByYear W21142189012014 @default.
• W2114218901 countsByYear W21142189012015 @default.
• W2114218901 countsByYear W21142189012016 @default.
• W2114218901 countsByYear W21142189012017 @default.
• W2114218901 countsByYear W21142189012018 @default.
• W2114218901 countsByYear W21142189012019 @default.
• W2114218901 countsByYear W21142189012020 @default.
• W2114218901 countsByYear W21142189012021 @default.
• W2114218901 countsByYear W21142189012022 @default.
• W2114218901 countsByYear W21142189012023 @default.
• W2114218901 crossrefType "journal-article" @default.
• W2114218901 hasAuthorship W2114218901A5000550995 @default.
• W2114218901 hasAuthorship W2114218901A5032933055 @default.
• W2114218901 hasAuthorship W2114218901A5034383160 @default.
• W2114218901 hasAuthorship W2114218901A5048913575 @default.
• W2114218901 hasAuthorship W2114218901A5049269121 @default.
• W2114218901 hasAuthorship W2114218901A5049957859 @default.
• W2114218901 hasAuthorship W2114218901A5072567218 @default.
• W2114218901 hasAuthorship W2114218901A5073053873 @default.
• W2114218901 hasAuthorship W2114218901A5074935860 @default.
• W2114218901 hasAuthorship W2114218901A5080129058 @default.
• W2114218901 hasAuthorship W2114218901A5087771312 @default.
• W2114218901 hasAuthorship W2114218901A5090610183 @default.
• W2114218901 hasConcept C126322002 @default.
• W2114218901 hasConcept C134018914 @default.
• W2114218901 hasConcept C165220095 @default.
• W2114218901 hasConcept C185592680 @default.
• W2114218901 hasConcept C190283241 @default.
• W2114218901 hasConcept C2776151105 @default.
• W2114218901 hasConcept C2776828364 @default.
• W2114218901 hasConcept C2777448766 @default.
• W2114218901 hasConcept C2777622882 @default.
• W2114218901 hasConcept C2779306644 @default.
• W2114218901 hasConcept C2779385521 @default.
• W2114218901 hasConcept C2779768347 @default.
• W2114218901 hasConcept C2780963292 @default.
• W2114218901 hasConcept C519581460 @default.

• next